Despite extensive and costly efforts, attempts to develop a vaccine ag
ainst human immunodeficiency virus (HIV), the causative agent of the a
cquired immunodeficiency syndrome (AIDS), have been unsuccessful. Usin
g the Maginot Line as a metaphor, we discuss the reasons why an antibo
dy-based vaccine strategy against HIV has failed. The concept of a vac
cine that exclusively promotes cell-mediated immunity against the viru
s is outlined, and important factors in the formulation of this novel
vaccine are delineated. In particular, vaccine adjuvants and HIV pepti
des that elicit a cell-mediated immune response are crucial components
of this immunization strategy. Examination of primate immune systems
that resist retroviral pathogenicity will also play an important role
in the development of a successful AIDS vaccine.